Rockefeller Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Rockefeller Capital Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-87,803	Closed	-$4K	–	2076
2023 Q1	$4K	Sell	87,803 -36,600	-29%	-$3.27K	﹤0.01%	1965
2022 Q4	$10K	Sell	124,403 -3,500	-3%	-$466	﹤0.01%	3096
2022 Q3	$26K	Sell	127,903 -1,150	-0.9%	-$349	﹤0.01%	2661
2022 Q2	$29K	Sell	129,053 -4,429	-3%	-$3.57K	﹤0.01%	2544
2022 Q1	$102K	Buy	133,482 +17,560	+15%	+$12.8K	﹤0.01%	1974
2021 Q4	$139K	Buy	115,922 +69,843	+152%	+$79.6K	﹤0.01%	1793
2021 Q3	$46K	Buy	46,079 +41,079	+822%	+$43.1K	﹤0.01%	2176
2021 Q2	$5K	Buy	+5,000	New	+$4.42K	﹤0.01%	3053

Other funds holding GRNAW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Rockefeller Capital Management's GRNAW Position: Q2 2023 in Review

Rockefeller Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2023, closing a stake of 87,803 shares — an estimated $4K sold.

Rockefeller Capital Management first reported a position in GRNAW in Q2 2021 and held it in 8 quarters. The position peaked at $139K in Q4 2021. 22 funds tracked by Wall St. Rank hold GRNAW as of Q2 2023.

Rockefeller Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2023 after selling out during the quarter.
Rockefeller Capital Management sold 87,803 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2023, an estimated $4K.
Rockefeller Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q2 2021 and held it in 8 quarters.
Rockefeller Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $139K in Q4 2021.
22 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.